Safety Study [resa]    
ANEMIA, SEVERE [dsyn]    
Based [ftcn]    
Triple [qnco]    
therapy [ftcn]    
Chronic hepatitis C [dsyn]    
Addition [ftcn]    
Hepatitis C Virus NS3/4A Protease Inhibitors [moft]    
Combination [qlco]    
Regimen [topp]    
Triple [qnco]    
therapy [ftcn]    
Improved [qlco]    
Treatment Outcome [qlco]    
ANEMIA [dsyn]    
Adverse Effect [patf]    
Study [mnob]    
ANEMIA, SEVERE [dsyn]    
Based [ftcn]    
Triple [qnco]    
therapy [ftcn]    
retrospective [resa]    
Multicenter Study [resa]    
CONSIST [qlco]    
Consecutive [qlco]    
-- Japanese [popg]    
Hepatitis C virus genotype 1 [virs]    
Patients [podg]    
Treated [ftcn]    
Real [qlco]    
World [popg]    
Clinical setting [spco]    
Genotype [orga]    
Patients [podg]    
Logistic Regression [resa]    
Propensity Score [qnco]    
MATCHING [resa]    
ANEMIA, SEVERE [dsyn]    
SCORE [qnco]    
MATCHING [resa]    
Entire [qnco]    
Study Population [popg]    
matched [resa]    
Pair [qlco]    
ANEMIA, SEVERE [dsyn]    
Nadir [qlco]    
treatment [ftcn]    
Patients [podg]    
Treated [ftcn]    
treatment [ftcn]    
Low Risk [fndg]    
ANEMIA, SEVERE [dsyn]    
Odds Ratio [qnco]    
Genotype [orga]    
hemoglobin level [lbtr]    
Estimated Glomerular Filtration Rate [lbpr]    
baseline [bodm]    
Independent [idcn]    
ANEMIA, SEVERE [dsyn]    
Treated [ftcn]    
Based [ftcn]    
Triple [qnco]    
therapy [ftcn]    
Low Risk [fndg]    
ANEMIA, SEVERE [dsyn]    
Treated [ftcn]    
Genotype [orga]    
Useful [qlco]    
treatment [ftcn]    
ANEMIA [dsyn]    
Related [qlco]    
adverse effects [ftcn]    
